These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 32763782)

  • 21. Identification and Development of Inflammatory Response-Related Genes Signature Associated With Prognosis Evaluation and Immune Status of Bladder Cancer.
    Zheng H; Luo W; Li Y; Peng G; Zhou D; Tang D; Cheng J; Wu S
    Front Cell Dev Biol; 2022; 10():837849. PubMed ID: 35309900
    [No Abstract]   [Full Text] [Related]  

  • 22. Development of a prognostic signature based on immune-related genes and the correlation with immune microenvironment in breast cancer.
    Dong M; Cui X; Wang G; Zhang Q; Li X
    Aging (Albany NY); 2022 Jul; 14(13):5427-5448. PubMed ID: 35793235
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A signature of seven immune-related genes predicts overall survival in male gastric cancer patients.
    Xu X; Lu Y; Wu Y; Wang M; Wang X; Wang H; Chen B; Li Y
    Cancer Cell Int; 2021 Feb; 21(1):117. PubMed ID: 33602220
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Screening and identification of immune-related genes for immunotherapy and prognostic assessment in colorectal cancer patients.
    Wang S; Cheng L; Jing F; Li G
    BMC Med Genomics; 2022 Aug; 15(1):177. PubMed ID: 35941638
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rac3 Expression and its Clinicopathological Significance in Patients With Bladder Cancer.
    Chen M; Nie Z; Cao H; Gao Y; Wen X; Zhang C; Zhang S
    Pathol Oncol Res; 2021; 27():598460. PubMed ID: 34257551
    [No Abstract]   [Full Text] [Related]  

  • 26. Development of an Immunogenomic Landscape-Based Prognostic Index of Head and Neck Squamous Cell Carcinoma.
    Long J; Zhang S; Zeng X; Ouyang Y; Wang Y; Hu Z; Ye Y; Wu W; Jin F; Zhou S; Zeng Z
    Front Mol Biosci; 2020; 7():586344. PubMed ID: 33330624
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic model of 10 immune-related genes and identification of small molecule drugs in bladder urothelial carcinoma (BLCA).
    Xing Q; Liu S; Jiang S; Li T; Wang Z; Wang Y
    Transl Androl Urol; 2020 Oct; 9(5):2054-2070. PubMed ID: 33209669
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of a four immune-related genes signature based on an immunogenomic landscape analysis of clear cell renal cell carcinoma.
    Gao X; Yang J; Chen Y
    J Cell Physiol; 2020 Dec; 235(12):9834-9850. PubMed ID: 32452055
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of an immune-related long non-coding RNA signature and nomogram as prognostic target for muscle-invasive bladder cancer.
    Song Y; Jin D; Chen J; Luo Z; Chen G; Yang Y; Liu X
    Aging (Albany NY); 2020 Jun; 12(12):12051-12073. PubMed ID: 32579540
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of an immune-related gene-based signature to predict prognosis of patients with gastric cancer.
    Qiu XT; Song YC; Liu J; Wang ZM; Niu X; He J
    World J Gastrointest Oncol; 2020 Aug; 12(8):857-876. PubMed ID: 32879664
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of a prognostic and therapeutic immune signature associated with hepatocellular carcinoma.
    Peng Y; Liu C; Li M; Li W; Zhang M; Jiang X; Chang Y; Liu L; Wang F; Zhao Q
    Cancer Cell Int; 2021 Feb; 21(1):98. PubMed ID: 33568167
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Construction and verification of a prognostic risk model based on immunogenomic landscape analysis of bladder caner.
    Zhang Y; Xie Y; Feng Y; Wang Y; Xu X; Zhu S; Xu F; Feng N
    Gene; 2022 Jan; 808():145966. PubMed ID: 34530089
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Integrative bioinformatics analysis of a prognostic index and immunotherapeutic targets in renal cell carcinoma.
    Tao H; Li Z; Mei Y; Li X; Lou H; Dong L; Zhou L
    Int Immunopharmacol; 2020 Oct; 87():106832. PubMed ID: 32738597
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification and validation of basement membrane-related genes predicting prognosis and immune infiltration associated with bladder cancer.
    Lai F; He L; Lia T; Yang Z; Huang C
    Medicine (Baltimore); 2024 Jul; 103(29):e38858. PubMed ID: 39029072
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification and prognostic value of a glycolysis-related gene signature in patients with bladder cancer.
    Wu Z; Wen Z; Li Z; Yu M; Ye G
    Medicine (Baltimore); 2021 Jan; 100(3):e23836. PubMed ID: 33545950
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Analysis of PTPN6 for Bladder Cancer: An Exploratory Study Based on TCGA.
    Shen C; Liu J; Wang J; Yang X; Niu H; Wang Y
    Dis Markers; 2020; 2020():4312629. PubMed ID: 32454905
    [No Abstract]   [Full Text] [Related]  

  • 37. Development and validation of an immune gene-set based prognostic signature for soft tissue sarcoma.
    Shen R; Liu B; Li X; Yu T; Xu K; Ma J
    BMC Cancer; 2021 Feb; 21(1):144. PubMed ID: 33557781
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A five-immune-related genes-based prognostic signature for colorectal cancer.
    Zhu L; Wang H; Wang Z
    Int Immunopharmacol; 2020 Nov; 88():106866. PubMed ID: 32781411
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A zinc finger protein gene signature enables bladder cancer treatment stratification.
    Zhang J; Zhang C; Cao P; Zheng X; Yu B; Cao H; Gao Z; Zhang F; Wu J; Cao H; Hao C; Sun Z; Wang W
    Aging (Albany NY); 2021 May; 13(9):13023-13038. PubMed ID: 33962398
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Establishment of an immune-related gene prognostic model for head and neck tumors.
    Zhou F; Chen AX; Lv HY; Liang DH; Yu HS
    J Biol Regul Homeost Agents; 2021; 35(3):975-986. PubMed ID: 34159769
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.